TRL-345

N/A

Report date: 2023/01/02 21:19:28

Base Information

Drug NameTRL-345
Drug Alias NameCMV-345TRL-345
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunomodulatorsVirus internalization inhibitorsEnvelope glycoprotein B, gB inhibitors
TargetsEnvelope glycoprotein B, gB
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTrellis Bioscience LLC
China Registration ClassN/A

Develop Information

Active CompaniesTrellis Bioscience LLC
Inactive CompaniesN/A
Active IndicationsCytomegalovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A